LOUISVILLE, Colo.–(BUSINESS WIRE)–Infleqtion (NYSE: INFQ), a global leader in quantum computing and quantum sensing powered by neutral-atom technology, announced it signed a Letter of Intent (LOI) with the U.S. Department of Commerce’s CHIPS Research and Development Office for $100 million in proposed funding contingent on achievement of certain development milestones to accelerate U.S. based quantum computing technologies. The investment will accelerate Infleqtion’s development of neutral-at
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
